Schonfeld Strategic Advisors LLC Seres Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $1.04 Million - $1.46 Million	222,257 New	222,257 $1.06 Million
Q3 2021 Nov 16, 2021	SELL	$5.46 - $22.6 $582,046 - $2.41 Million	-106,602 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $1.97 Million - $2.6 Million	106,602 New	106,602 $2.54 Million
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $255,469 - $418,356	-14,466 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $57,334 - $93,042	2,466 Added 20.55%	14,466 $355,000

Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $44,880 - $344,880	12,000 New	12,000 $0

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.